Nitric oxide donation lowers blood pressure in adrenocorticotrophic hormone-induced hypertensive rats

被引:7
作者
Andrews, MC [1 ]
Schyvens, CG [1 ]
Zhang, Y [1 ]
McKenzie, KUS [1 ]
Whitworth, JA [1 ]
机构
[1] Australian Natl Univ, John Curtin Sch Med Res, High Blood Pressure Res Unit, Canberra, ACT 2601, Australia
关键词
nitric oxide; isosorbide dinitrate; adrenocorticotrophic hormone; hypertension; glucocorticoids;
D O I
10.1081/CEH-200031824
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adrenocorticotrophic hormone (ACTH) elevates systolic blood pressure (SBP) and lowers plasma reactive nitrogen intermediates in rats. We assessed the ability of NO donation from isosorbide dinitrate (ISDN) to prevent or reverse the hypertension caused by ACTH. In the prevention study, male Sprague Dawley rats were treated with ACTH (0.2 mg/kg/day) or saline control for 8 days, with either concurrent ISDN (100 mg/kg/day) via the drinking water or water alone. Animals receiving ISDN via the drinking water were provided with nitrate-free water for 8 hours every day. In the reversal study ISDN (100 mg/kg) or vehicle was given as a single oral dose on day 8. SBP was measured daily by the indirect tail-cuff method in conscious, restrained rats. ACTH caused a significant increase in SBP compared with saline (P < 0.0015). In the prevention study, chronic administration of ISDN (100 mg/kg/day) did not affect the SBP in either group. In the reversal study, ISDN significantly lowered SBP in ACTH-treated rats at 1 and 2.5 hours (132 +/- 3 mmHg (1 h) and 131 +/- 2 mmHg (2.5 h) versus 143 +/- 3 mmHg (0 h), P < 0.002), but not to control levels. It had no effect in control (saline treated) rats. In conclusion, the lowering of SBP by NO donation is consistent with the notion that ACTH-induced hypertension involves an impaired bioavailability or action of NO in vivo.
引用
收藏
页码:499 / 509
页数:11
相关论文
共 38 条
[1]   Identification of the enzymatic mechanism of nitroglycerin bioactivation [J].
Chen, ZQ ;
Zhang, J ;
Stamler, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) :8306-8311
[2]  
Dikalov, 1998, J Cardiovasc Pharmacol Ther, V3, P51, DOI 10.1177/107424849800300107
[3]   Vasopressin V1A receptor antagonism does not reverse adrenocorticotrophin-induced hypertension in the rat [J].
Fraser, TB ;
Turner, SW ;
Wen, C ;
Li, M ;
Burrell, LM ;
Whitworth, JA .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2000, 27 (11) :866-870
[4]   Adrenocorticotrophic hormone-induced hypertension in the rat: Effects of the endothelin antagonist bosentan [J].
Fraser, TB ;
Mangos, GJ ;
Turner, SW ;
Whitworth, JA .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (08) :628-633
[5]  
Gerová M, 2001, PHYSIOL RES, V50, P165
[6]   Nitrate tolerance - A unifying hypothesis [J].
Gori, T ;
Parker, JD .
CIRCULATION, 2002, 106 (19) :2510-2513
[7]   GLUCOCORTICOIDS MODULATE VASCULAR REACTIVITY IN THE RAT [J].
GRUNFELD, JP ;
ELOY, L .
HYPERTENSION, 1987, 10 (06) :608-618
[8]   ROLE OF L-ARGININE NITRIC-OXIDE PATHWAY IN HYPERTENSION [J].
HISHIKAWA, K ;
NAKAKI, T ;
SUZUKI, H ;
KATO, R ;
SARUTA, T .
JOURNAL OF HYPERTENSION, 1993, 11 (06) :639-645
[9]   Vascular hyporeactivity persists despite increased contractility after long-term administration of isosorbide dinitrate in portal hypertensive rats [J].
Huang, YT ;
Lin, HC ;
Tsai, JF ;
Hou, MC ;
Lee, SD ;
Hong, CY .
JOURNAL OF HEPATOLOGY, 1998, 28 (06) :1037-1044
[10]   Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences [J].
John, S ;
Schmieder, RE .
JOURNAL OF HYPERTENSION, 2000, 18 (04) :363-374